Generic for Ddavp: Desmopressin Acetate

Yes. The generic name for Ddavp is desmopressin acetate. 12 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB, AP. Generics match 4 of the 6 Ddavp products the Orange Book lists.

Run it in Rivvi

Map Ddavp and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Ddavp products in the Orange Book

Ddavp products and approved generics
Form and route	Strength	Brand status	Brand TE	Active generics	Generic TE codes
injectable, injection	0.004MG/ML	Marketed (Rx)	AP	9	AP
injectable, injection	0.015MG/ML	Discontinued	None	0	None
solution, nasal	0.01%	Discontinued	None	0	None
spray, metered, nasal	0.01MG/SPRAY	Discontinued	None	2	AB
tablet, oral	0.1MG	Marketed (Rx)	AB	5	AB
tablet, oral	0.2MG	Marketed (Rx)	AB	5	AB

NDA 018938, 017922, 019955, held by J MOLNER HOLDINGS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic desmopressin acetate

Approved generic versions of Ddavp
Company	ANDA	TE code	Approved	Strengths
MEITHEAL PHARMACEUTICALS INC	074888	AP (A-rated, therapeutically equivalent)	October 15, 1997	0.004MG/ML
APOTEX INC	076703	AB (A-rated, therapeutically equivalent)	January 27, 2005	0.01MG/SPRAY
APOTEX INC	077414	AB (A-rated, therapeutically equivalent)	March 7, 2006	0.1MG, 0.2MG
HERITAGE PHARMA LABS INC	207880	AB (A-rated, therapeutically equivalent)	May 26, 2017	0.1MG, 0.2MG
SAGENT PHARMACEUTICALS INC	204695	AP (A-rated, therapeutically equivalent)	August 22, 2017	0.004MG/ML
SAGENT PHARMACEUTICALS INC	204751	AP (A-rated, therapeutically equivalent)	August 22, 2017	0.004MG/ML
ZYDUS PHARMACEUTICALS USA INC	091345	AB (A-rated, therapeutically equivalent)	October 3, 2017	0.01MG/SPRAY
ABHAI LLC	210371	AB (A-rated, therapeutically equivalent)	January 28, 2019	0.1MG, 0.2MG
NOVAST LABORATORIES LTD	208357	AB (A-rated, therapeutically equivalent)	June 6, 2019	0.1MG, 0.2MG
UBI PHARMA INC	210218	AP (A-rated, therapeutically equivalent)	February 14, 2020	0.004MG/ML
UBI PHARMA INC	210223	AP (A-rated, therapeutically equivalent)	September 17, 2020	0.004MG/ML
DR REDDYS LABORATORIES LTD	215961	AP (A-rated, therapeutically equivalent)	August 19, 2022	0.004MG/ML
GLAND PHARMA LTD	216922	AP (A-rated, therapeutically equivalent)	November 16, 2022	0.004MG/ML
GLAND PHARMA LTD	216904	AP (A-rated, therapeutically equivalent)	March 20, 2023	0.004MG/ML
AUROBINDO PHARMA LTD	213095	AB (A-rated, therapeutically equivalent)	March 21, 2024	0.1MG, 0.2MG
CAPLIN STERILES LTD	219981	AP (A-rated, therapeutically equivalent)	February 27, 2026	0.004MG/ML

Ddavp NDC codes

Questions

Is there a generic for Ddavp?

Yes. The generic name for Ddavp is desmopressin acetate. 12 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB, AP. Generics match 4 of the 6 Ddavp products the Orange Book lists.

What is the generic name for Ddavp?

The active ingredient in Ddavp is desmopressin acetate, per the FDA Orange Book.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

Generic for Ddavp